A Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years
Clinical trial NCT04450498 · COMPLETED
Trial details
- NCT number
- NCT04450498
- Sponsor
- Walvax Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2021-07-30
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.